Atherosclerosis is accelerated in diabetes mellitus mainly due to the reduced availability and function of endothelial progenitor cells (EPCs). The purpose of this study was to determine the protective effects of the anthocyanin cyanidin-3-O-b-glucoside (C3G) on EPC function and endothelial repair in diabetic apolipoprotein E-deficient (apoE 2/2 ) mice. Diabetes mellitus was induced in 8-wk-old male apoE 2/2 mice with streptozotocin. Diabetic apoE 2/2 mice were fed the AIN-93 diet or an AIN-93 diet supplemented with C3G (0.2% wt:wt) for 6 wk. Sham-injected apoE 2/2 mice fed the AIN-93 diet served as nondiabetic controls.
Introduction
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease (1, 2) . The mechanisms of the endothelial dysfunction in diabetes are mainly due to the imbalance of endothelial damage and endothelial repair (3, 4) . Endothelial progenitor cells (EPCs) 6 are bone marrow-derived cells with the potential to differentiate into mature endothelial cells and take part in endothelial repair and maintenance under physiologic conditions (5, 6) . In response to vascular damage, EPCs are mobilized from bone marrow into the circulation, differentiate into functional endothelial cells, and subsequently migrate to the area of injury to facilitate re-endothelialization (6) . Diabetic vascular complications may be in part due to the inability of EPCs to exert their reparative function (7) . Diabetic EPCs display functional impairments, including decreased migration/ homing process, reduced proliferative capacity, and incorporation into tubular structures (8) (9) (10) . In addition, the number of circulating EPCs is also significantly decreased in diabetic patients and has been considered to be a biological marker of atherosclerosis in diabetes (11, 12) . Strategies to increase circulating EPC numbers and to improve EPC function are essential to ensure the therapeutic viability of diabetic-induced vascular disorders.
Increasing evidence shows that foods rich in anthocyanins, such as blueberries, purple grapes, and corn, may help prevent cardiovascular disease, particularly with respect to their antioxidant 1 Supported by grants from the National Natural Science Foundation of China (no. 81072301) and the National Natural Science Foundation from Guangdong Province (no. S2012020011104); the Guangdong Province Universities and Colleges Funded Scheme (2011); and the Guangzhou City Science and Technology Project (no. 12C22061588). 2 Author disclosures: Y. Zhang, X. Wang, Y. Wang, Y. Liu, and M. Xia, no conflicts of interest. 3 Supplemental Figure 1 is available from the ''Online Supporting Material'' link in the online posting of the article and from the same link in the online table of contents at http://jn.nutrition.org. and antiinflammatory effects (13) (14) (15) . Many studies have focused on cyanidin-3-O-b-glucoside (C3G), the best-known and most investigated anthocyanin (16) . We recently showed that C3G supplementation significantly improved endothelial dysfunction and attenuated atherosclerotic lesion progression in hypercholesterolemic apolipoprotein E-deficient (apoE 2/2 ) mice (17), the underlying cause of which may associated with the induction of oxysterol efflux from endothelial cells by anthocyanin (18) . Despite these promising findings, the protective role of anthocyanin on diabetes-accelerated atherosclerosis, which is characterized by the disruption of endothelial repair, remains poorly demonstrated. The purpose of this study was to investigate whether anthocyanin C3G is sufficient to prevent diabetesinduced impairment in EPC functions and vascular repair in diabetic apoE 2/2 mice.
Materials and Methods
Materials. Anthocyanin C3G was provided by Polyphenol AS. Streptozotocin and other reagents were purchased from Sigma-Aldrich unless otherwise indicated.
Animal protocol and diet. Male homozygous apoE 2/2 mice (C57BL/6 genetic background) were obtained at 6 wk of age from Jackson Laboratories. The mice were fed an AIN-93 purified diet (19) and given free access to food and water throughout the study. After 2 wk of acclimatization, the mice were rendered diabetic by 5 consecutive daily i.p. injections of streptozotocin (Sigma-Aldrich) at a dose of 55 mg Á kg 21 (17) . Body weight and food intake were recorded weekly. At the end of experiment, mice were killed by using CO 2 , and serum and tissue samples were collected and stored at 280°C until analysis.
Measurement of blood glucose and cholesterol. Blood samples were collected from the lateral saphenous vein at the end of the study. Blood glucose and serum lipid concentrations were measured as previously described (17) .
Vascular reactivity. The endothelium-dependent relaxation response to acetylcholine and the endothelium-independent relaxation response to sodium nitroprusside were examined as previously described (17) .
Quantification of atherosclerotic lesion area. Atherosclerosis was determined by cross-sectional assessment of the aortic sinus. The base of each heart was cryosectioned and stained as previously described (17) .
Immunohistochemical analysis. Aortas were fixed in 4% buffered formalin, cut to 5-mm thick sections, and stained for the endothelial cells marker CD31. Briefly, paraffin-embedded sections were incubated with anti-CD31 antibody (1:50; Abcam), followed by biotinylated goat antirabbit antibody, and then colored with diaminobenzidine. Sections were counterstained with hematoxylin.
Isolation of EPCs. EPCs were isolated from blood and bone marrow of both nondiabetic and diabetic apoE 2/2 mice. Mononuclear cells were isolated from blood with Histopaque 1083 (Sigma-Aldrich) by density gradient centrifugation, and RBCs were lysed with Red Blood Cell Lysis Buffer (Beyotime). Cells were washed 3 times in Stain Buffer (BD Pharmingen) and then used for testing by flow cytometry. Bone marrow-derived EPCs were isolated and cultured according to previously described methods (21) . Briefly, mononuclear cells were obtained by flushing the femurs and tibias of the mice. Immediately after isolation, cells were plated onto fibronectin (Sigma)-precoated 6-well plates at a density of 5 310 6 cells/well and cultured in Endothelial Cell Growth Medium 2 (EGM-2; Lonza) supplemented with 20% FBS (Hyclone) in 37°C 5% CO 2 . After 4 d in culture, nonadherent cells were washed away, and fresh medium was added. EPCs after 7 d in culture were used for all experiments.
Flow cytometry analysis. The number of circulating EPCs was determined by quantification of the number of Sca-1/Flk-1 doublepositive cells by fluorescence-activated cell sorter (22) . In brief, the cells were incubated with rat anti-mouse Sca-1-FITC (fluorescein isothiocyanate) antibody (BD) and rat anti-mouse Flk-1-phycoerythrin antibody (BD). The FITC or PE-conjugated isotype antibody was used as a control. Data were analyzed by using FACSDiVa software (BD).
EPC adhesion assay. For adhesion assay, 1.0 3 10 4 EPCs were plated in 96-well plates coated with 1.0 mg/mL fibronectin. After 1-h incubation in EGM-2 plus 10% FBS, nonadherent cells were washed away, and adherent cells were fixed with 4% paraformaldehyde. Nuclei were stained with Hoechst 33258 and were counted at 5 random fields in each well, at a magnification 3100 for each sample (23) .
EPC migration assay. EPC migration was measured by using Transwell chambers (Corning) with 8-mm-pore-size filters. EPCs were plated at a density of 5 3 10 4 cells per well in the upper chamber with 200 mL of EBM-2 (Lonza), whereas 800 mL of EBM-2 with recombinant human vascular endothelial growth factor (50 mg/L; Peprotech) was placed in the lower chamber. EPCs were allowed to migrate in a humidified incubator at 37°C for 24 h. The cells on the membraneÕs lower side were fixed with 4% paraformaldehyde and stained with hematoxylin. Nonmigrated cells were removed by gently wiping the membraneÕs upper surface with a cotton swab. The number of EPCs was counted at a magnification of 3100, and the mean value of 5 random fields was determined for each sample (24) .
EPC tube formation assay. An EPC tube formation assay was performed by using an In Vitro Angiogenesis Assay Kit (Millipore). ECMatrix gel solution was thawed at 4°C overnight, mixed with ECMatrix diluent buffer, and placed in a 96-well plate at 37°C for 1 h to allow the matrix solution to solidify. EPCs were harvested as with trypsin/EDTA, and then 1 3 10 4 EPCs were placed on a matrix solution with EGM-2 medium and incubated at 37°C for 4 h. Tubule formation was inspected under an inverted light microscope (3100 magnification). Tube formation was counted in 5 random fields with the Image-Pro Plus (Media Cybernetics) (23) .
Re-endothelialization assay. Endothelial recovery was evaluated by staining denuded areas with Evans blue dye (Sigma). The bluestained and total luminal areas were determined respectively, and the re-endothelialized area was expressed as a percentage of the total surface (% area) (25) .
Western blot. Aliquots (40 mg) of protein extracts were separated by SDS-PAGE and then transferred onto an Immobilon-P membrane (Millipore). After blocking, the blots were incubated with various primary antibodies followed by horse radish peroxidase-labeled secondary antibodies. The protein bands were detected with a SuperSignal West Pico Chemiluminescent kit (Thermo). The primary antibodies used were as follows: anti-AMP-activated protein kinase a (anti-AMPKa), anti-endothelial nitric oxide synthase (anti-eNOS), anti-phosphoAMPKa (Thr172), and anti-phospho-eNOS (Ser1177) (all from Cell Signaling Technology).
Statistical analysis. Data (mean 6 SD) were analyzed by using GraphPad Prism (version 5.0; GraphPad Software) and SPSS (version 17.0; IBM SPSS Statistics, IBM Corporation). All variables were tested by Shapiro-Wilk test for normal distribution. Differences were compared by using 1-way ANOVA or Kruskal-Wallis H test (when variances were unequal). Pairwise multiple comparisons were made with the Bonferroni method to detect significant differences between groups when the H test was significant. P < 0.05 was considered significant.
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.18 g; P < 0.05), and the daily food intake of diabetic animals (5.45 6 0.78 g) was higher than their nondiabetic counterparts (3.07 6 0.52 g; P < 0.01). Supplementation with C3G did not cause significant differences in body weight (17.8 6 2.36 g) and food intake (5.14 6 0.82 g). The amount of C3G consumed by the diabetic mice was 10.3 6 1.64 mg/d. Serum glucose and lipid concentrations. The serum total and LDL-cholesterol and glucose concentrations were higher in diabetic apoE 2/2 mice than in nondiabetic controls (P < 0.05; Table 1 ). Supplementation with C3G did not cause significant changes in blood glucose or serum cholesterol relative to untreated diabetic mice.
Endothelium-dependent relaxation response. The sensitivity and maximal response of thoracic arteries to acetylcholine in diabetic apoE 2/2 mice were markedly reduced compared with that in nondiabetic apoE 2/2 mice. Diabetic apoE 2/2 mice treated with C3G displayed a significant improvement in acetylcholineelicited relaxation compared with diabetic apoE 2/2 mice (Fig.  1A) . There was no obvious differences in aortic smooth muscle relaxation to sodium nitroprusside among the 3 groups (Fig. 1B) .
Number of circulating EPCs. The percentage of circulating EPCs (Sca-1/Flk-1 double-positive cells) in diabetic apoE
2/2 mice was dramatically lowered, from 10.3 6 1.09% to 0.60 6 0.33% in mononuclear cells (P < 0.01). The percentage of circulating EPCs (9.10 6 2.57%) was much higher in C3G-treated diabetic apoE 2/2 mice compared with untreated diabetic mice (P < 0.01).
EPC functions and vascular repair. In vitro analysis of EPC adhesion, migration, and angiogenesis showed significant impairment of EPC functions in diabetic apoE 2/2 mice compared with nondiabetic mice. Supplementation with C3G significantly increased EPC adhesion (P < 0.01; Fig. 2A ), promoted EPC migration (P < 0.01; Fig. 2B ), and enhanced angiogenesis (P < 0.05; Fig. 2C ). Compared with nondiabetic apoE 2/2 mice, re-endothelialization was impaired in diabetic apoE 2/2 mice. On the contrary, C3G supplementation significantly reversed diabetesinduced impairment in re-endothelialization (P < 0.05; Fig. 2D ).
Endothelial CD31 level. CD31 staining was weak in the intima of diabetic mice, whereas nondiabetic mice demonstrated strong staining. C3G intervention restored the expression to the level of staining of nondiabetic controls (Fig. 3A) . Optical density analysis of immunohistochemical staining provided quantification of the changes in CD31 expression (Fig. 3B) .
AMPK activation and eNOS expression. Compared with EPCs isolated from nondiabetic apoE
2/2 mice, EPCs from diabetic mice showed a significant decrease in the phosphorylation levels of both AMPK (P < 0.05; Fig. 4A ) and eNOS protein (P < 0.05; Fig. 4B ), which was significantly reversed by C3G treatment.
Lesion area of atherosclerosis in aortic sinus. The mean atherosclerotic lesion area in the aortic sinus in the diabetic mice was 2.5-fold greater than in nondiabetic apoE 2/2 mice (P < 0.001). Supplementation with C3G significantly reduced the mean lesion area versus that in untreated diabetic mice (P < 0.05 vs. untreated diabetic mice; Supplemental Fig. 1A, B) .
Discussion
To our knowledge, the present study is the first in vivo characterization showing that anthocyanin C3G supplementation potentially increased the number of circulating EPCs and largely improved the impaired EPC functions, including adhesion, migration, and tube formation capacities, under diabetic conditions. Correction of all these abnormalities by C3G is associated with the restoration of the activities of phosphorylated (p-) AMPK and p-eNOS and an increase in vascular repair in diabetic animals. Finally, C3G intake improves the deterioration in endothelium-dependent relaxation and prevents the acceleration of atherosclerosis in diabetic apoE 2/2 mice. Thus, our current findings indicate direct beneficial effects of anthocyanin C3G on EPCs and that it ameliorated diabetes-induced atherogenesis.
Many studies have identified that the intake of anthocyaninrich food significantly improved the high-fat-diet-induced features of metabolic syndrome in animal models (26) (27) (28) . Furthermore, purified anthocyanins from berries are more effective in preventing increased obesity (28) . However, the beneficial effects of purified anthocyanin on diabetes-accelerated atherogenesis have not been investigated previously. We observed that supplementation of C3G for 6 wk strongly ameliorated the enhanced atherosclerotic plaque volume in diabetic apoE 2/2 mice. The effect of C3G on atherogenesis was independent of any significant change in the large increases in hyperglycemia induced by streptozotocin injection. This suggests that the effect of C3G on atherogenesis is not related to any metabolic influence or alteration in severity of diabetes.
Diabetes mellitus contributes to endothelial cell injury and dysfunction, leading to the development of diabetes-related vascular complications (29) . Here we observed that the endotheliumdependent relaxation response to acetylcholine was markedly impaired in apoE 2/2 mice injected with streptozotocin compared with the non-streptozotocin-injected controls. C3G treatment robustly prevented the damage by endothelium-dependent vasodilatation associated with diabetes in apoE 2/2 mice. The effects of C3G were likely exerted directly on endothelial cells because smooth muscle relaxation responses to sodium nitroprusside were unaffected.
EPCs, immature cells capable of differentiating into mature endothelial cells, play a critical role in maintaining endothelial function (30) . Dysfunction of EPCs potently initiates and accelerates the development of diabetic vascular disease due to an insufficient endothelial cell repair (9, 31) . Both type 1 and type 2 diabetes mellitus have been associated with low concentrations and poor function of circulating EPCs and causally associated with diabetes-induced impairment in vasculogenesis (7, 11) . This stipulation is verified by the current study, which showed that diabetic apoE 2/2 mice had decreased numbers of circulating EPCs, reduced adhesion ability and Matrigel tube formation (Millipore), and attenuated ex vivo angiogenesis compared with nondiabetic apoE 2/2 mice. C3G feeding elicited significant EPCmodulating effects, as evidenced by increased mobilization of EPCs into the circulation, incorporation of EPCs into injured blood vessel wall, and augmentation of endothelial repair in diabetic mice. Therefore, C3G appears to exert its protective effects against diabetes-induced impairment in re-endothelialization through its pleiotropic actions on almost all of the major steps involved in EPC-mediated neovascularization. The restoration of EPC number and function after C3G treatment was paralleled by increased concentrations of endothelial p-AMPK and p-eNOS.
Our study did have several limitations. This study involved the administration of an anthocyanin compound, C3G, but not natural berries or berry powder, which would have been more applicable to the clinical progression of atherosclerosis. Another issue was the amount of C3G consumed. Daily C3G intake, 10.3 mg/d per diabetic mouse, was higher than in previous reports, which may have been due to the greater food consumption of diabetic animals than nondiabetic mice. Finally, we used only a single dose of anthocyanin compound, which cannot provide a dose-dependent response of C3G on endothelial repair and angiogenesis in diabetic apoE 2/2 mice. In summary, our study indicates that the greater effect of the anthocyanin in the diabetic apoE 2/2 mice is likely related to preventing the deterioration EPC function and endothelial function that occur in the response to the diabetic milieu. Further EPC-based translational studies of anthocyanin intervention are needed to provide a novel and valid alternative in diabetic patients with advanced vascular complications.
